NCT03902951View on ClinicalTrials.gov

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Interventions
DRUG

Abiraterone Acetate

Given PO

DRUG

Apalutamide

Given PO

DRUG

Leuprolide Acetate

Given SC

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Janssen Inc.

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER